|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/50 | (2006.01) |
| A61K 47/60 | (2017.08) | ||
| A61K 47/60 | (2017.01) | ||
| A61K 38/50 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| C12N 9/78 | (2013.01) | ||
| C12N 9/78 | (2006.01) | ||
| C12Y 305/03006 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) |
| (11) | Number of the document | 3193913 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15842576.9 |
| Date of filing the European patent application | 2015-09-16 | |
| (97) | Date of publication of the European application | 2017-07-26 |
| (45) | Date of publication and mention of the grant of the patent | 2022-05-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/050354 |
| Date | 2015-09-16 |
| (87) | Number | WO 2016/044376 |
| Date | 2016-03-24 |
| (30) | Number | Date | Country code |
| 201462051182 P | 2014-09-16 | US |
| (72) |
SHOWALTER, Richard , US
ALMASSY, Robert , US
THOMSON, James A. , US
SISSON, Wes , US
SHIA, Wei-Jong , US
CHEN, Li-Chang , US
LEE, Yang , US
|
| (73) |
Polaris Group ,
P.O. Box 309
Ugland House, Grand Cayman, KY1-1104,
KY
|
| (54) | ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT |
| ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT |